Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Zai Lab Ltd ADR (ZLAB)

Zai Lab Ltd ADR (ZLAB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
32.53 +2.82 (+9.49%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.00 +0.47 (+1.44%) 17:54 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
31.13
Day High
32.70
Open 31.83
Previous Close 29.71 29.71
Volume 1,271,000 1,271,000
Avg Vol 1,655,545 1,655,545
Stochastic %K 43.55% 43.55%
Weighted Alpha +90.19 +90.19
5-Day Change +1.01 (+3.20%) +1.01 (+3.20%)
52-Week Range 15.00 - 39.77 15.00 - 39.77
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,257,048
  • Shares Outstanding, K 109,628
  • Annual Sales, $ 398,990 K
  • Annual Income, $ -257,100 K
  • EBIT $ -282 M
  • EBITDA $ -274 M
  • 60-Month Beta 1.09
  • Price/Sales 7.92
  • Price/Cash Flow N/A
  • Price/Book 3.75

Options Overview Details

View History
  • Implied Volatility 70.81% ( +4.14%)
  • Historical Volatility 99.68%
  • IV Percentile 59%
  • IV Rank 53.79%
  • IV High 127.18% on 06/17/24
  • IV Low 5.20% on 09/17/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 46
  • Volume Avg (30-Day) 283
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 5,417
  • Open Int (30-Day) 5,663

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.03
  • Low Estimate -0.50
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.24 +34.20%
on 04/10/25
Period Open: 35.09
39.77 -18.20%
on 03/28/25
-2.56 (-7.30%)
since 03/21/25
3-Month
24.24 +34.20%
on 04/10/25
Period Open: 26.63
39.77 -18.20%
on 03/28/25
+5.90 (+22.16%)
since 01/22/25
52-Week
15.00 +116.87%
on 04/23/24
Period Open: 14.99
39.77 -18.20%
on 03/28/25
+17.54 (+117.01%)
since 04/22/24

Most Recent Stories

More News
Zai Lab Flat as China Okays Application

Zai Lab Limited (NASDAQ: ZLAB) shares barely moved Monday, on word China’s National Medical Products ...

ZLAB : 32.53 (+9.49%)
NovoCure Q4 EPS Misses, Revenue Matches

NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.

NVCR : 16.51 (+5.97%)
MRK : 78.97 (+1.44%)
ZLAB : 32.53 (+9.49%)
RHHBY : 38.9800 (+0.46%)
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a very long time. A new treatment option that significantly raises their chances...

NVCR : 16.51 (+5.97%)
ZLAB : 32.53 (+9.49%)
Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges

The trial met its primary endpoint, showing a statistically significant improvement in median overall survival.

NVCR : 16.51 (+5.97%)
ZLAB : 32.53 (+9.49%)
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77%

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Although death rates for some cancers are declining, the world is facing a sharp increase in cancer...

ONCY : 0.6000 (+4.35%)
ZNTL : 1.4700 (+8.09%)
TIL : 16.49 (+3.06%)
IMRX : 1.3800 (unch)
ZLAB : 32.53 (+9.49%)
ONC.TO : 0.84 (+6.33%)
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END

ONCY : 0.6000 (+4.35%)
NTBL : 0.2479 (-27.68%)
JNJ : 157.75 (+0.53%)
ZLAB : 32.53 (+9.49%)
ONC.TO : 0.84 (+6.33%)
CRDF : 3.05 (+8.16%)
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months

Cathie Wood and Bill Gates like this stock, too.

ARKG : 21.30 (+4.26%)
ZLAB : 32.53 (+9.49%)
SDGR : 25.99 (-0.76%)
Qiming Venture Partners' portfolio company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange

/PRNewswire/ -- Qiming Venture Partners' portfolio company Tuhu Car, China's leading one-stop car service platform, successfully listed on the Hong Kong Stock...

ZLAB : 32.53 (+9.49%)
SDGR : 25.99 (-0.76%)
BILI : 16.70 (+3.15%)
ZH : 3.81 (+6.13%)
Why Shares of Zai Lab Limited Were Jumping on Tuesday

Zai Lab's shares benefited from positive clinical trial news.

GMAB : 20.27 (+1.00%)
ZLAB : 32.53 (+9.49%)
SGEN : 228.74 (-0.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 32.53 (+9.49%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 32.53 (+9.49%)
ROSEN, A TOP RANKED LAW FIRM, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation - ZLAB

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

ZLAB : 32.53 (+9.49%)
ZLAB ALERT: The Law Offices of Vincent Wong Investigate Zai Lab Limited for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced...

ZLAB : 32.53 (+9.49%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 32.53 (+9.49%)
ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB) concerning possible...

ZLAB : 32.53 (+9.49%)
ZLAB NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab Limited

/PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Zai Lab Limited ("Zai Lab") (NASDAQ: ZLAB) violated federal securities...

ZLAB : 32.53 (+9.49%)
ROSEN, A LEADING LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLAB

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

ZLAB : 32.53 (+9.49%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

ZLAB : 32.53 (+9.49%)
ZLAB INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLAB

/PRNewswire/ -- WHY: New York, N.Y., June 10, 2023. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities...

ZLAB : 32.53 (+9.49%)
ZLAB FRAUD ALERT: Jakubowitz Law is Investigating Zai Lab Limited in Connection with Potential Violations of Federal Securities Laws

/PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Zai Lab...

ZLAB : 32.53 (+9.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China....

See More

Key Turning Points

3rd Resistance Point 34.68
2nd Resistance Point 33.69
1st Resistance Point 33.11
Last Price 32.53
1st Support Level 31.54
2nd Support Level 30.55
3rd Support Level 29.97

See More

52-Week High 39.77
Last Price 32.53
Fibonacci 61.8% 30.31
Fibonacci 50% 27.39
Fibonacci 38.2% 24.46
52-Week Low 15.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.